Emily F. Mason

4.2k total citations · 1 hit paper
32 papers, 2.3k citations indexed

About

Emily F. Mason is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Emily F. Mason has authored 32 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Pathology and Forensic Medicine and 10 papers in Oncology. Recurrent topics in Emily F. Mason's work include Acute Myeloid Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Immune Cell Function and Interaction (5 papers). Emily F. Mason is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Immune Cell Function and Interaction (5 papers). Emily F. Mason collaborates with scholars based in United States, South Korea and Australia. Emily F. Mason's co-authors include Jeffrey C. Rathmell, Andrew N. Macintyre, Ryan D. Michalek, Sarah R. Jacobs, Valerie A. Gerriets, Sarah Sullivan, Amanda Nichols, Nancie J. MacIver, Jason L. Hornick and Jonathan L. Coloff and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Emily F. Mason

26 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets

2011 1.6k citations Ryan D. Michalek, Valerie A. Gerriets et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily F. Mason United States	12	1.2k	833	519	360	310	32	2.3k
Marjo M. P. C. Donners Netherlands	26	939 0.8×	951 1.1×	415 0.8×	293 0.8×	279 0.9×	51	2.3k
Yuan Yang Australia	32	1.3k 1.1×	1.1k 1.3×	391 0.8×	307 0.9×	130 0.4×	64	2.8k
Cong Yan United States	30	1.6k 1.3×	1.4k 1.7×	502 1.0×	649 1.8×	440 1.4×	69	3.2k
Jan Piet van Hamburg Netherlands	27	1.4k 1.2×	769 0.9×	182 0.4×	384 1.1×	176 0.6×	58	2.9k
Can Shi China	23	690 0.6×	947 1.1×	417 0.8×	160 0.4×	169 0.5×	43	2.0k
Trudy McGarry Ireland	24	553 0.5×	688 0.8×	280 0.5×	279 0.8×	208 0.7×	34	2.1k
Dick Wågsäter Sweden	31	949 0.8×	930 1.1×	405 0.8×	624 1.7×	428 1.4×	87	2.9k
Min Xie China	27	825 0.7×	1.9k 2.3×	724 1.4×	253 0.7×	804 2.6×	45	3.1k
Wei Tang China	27	562 0.5×	1.0k 1.2×	251 0.5×	398 1.1×	291 0.9×	73	2.5k
Guangjin Zhou United States	22	579 0.5×	1.5k 1.8×	354 0.7×	184 0.5×	257 0.8×	69	2.5k

Countries citing papers authored by Emily F. Mason

Since Specialization

Citations

This map shows the geographic impact of Emily F. Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily F. Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily F. Mason more than expected).

Fields of papers citing papers by Emily F. Mason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily F. Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily F. Mason. The network helps show where Emily F. Mason may publish in the future.

Co-authorship network of co-authors of Emily F. Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Emily F. Mason. A scholar is included among the top collaborators of Emily F. Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily F. Mason. Emily F. Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Huiying, et al.. (2025). ALK+ Anaplastic Large Cell Lymphoma Diagnosed on Paediatric Pericardial Effusion Cytology. Cytopathology. 36(3). 285–289.

Shaver, Aaron C., et al.. (2024). Flow Cytometric Assessment of Malignant Hematologic Disorders. Clinics in Laboratory Medicine. 44(3). 465–477.

Lee, Laura, et al.. (2024). Diagnosis of TP53-mutated myeloid disease by the ICC and WHO fifth edition classifications. Blood Advances. 9(3). 445–454. 4 indexed citations

Park, Silvia, Rahul Shah, Carlos Prieto‐Granada, et al.. (2024). GVHD like skin eruption post-autologous stem cell transplantation. Bone Marrow Transplantation. 59(6). 900–903.

Mason, Emily F., et al.. (2023). Diagnostic Utility of CD200 Immunohistochemistry in Distinguishing EBV-Positive Large B-Cell Lymphoma From Classic Hodgkin Lymphoma. American Journal of Clinical Pathology. 160(3). 284–291. 2 indexed citations

Kishtagari, Ashwin, Reena Jayani, Bhagirathbhai Dholaria, et al.. (2022). TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Blood. 140(Supplement 1). 11638–11640. 1 indexed citations

Weinberg, Olga K., Karen M. Chisholm, Chi Young Ok, et al.. (2021). Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group. Modern Pathology. 34(7). 1358–1366. 11 indexed citations

Mason, Emily F. & Alexandra E. Kovach. (2021). Update on Pediatric and Young Adult Mature Lymphomas. Clinics in Laboratory Medicine. 41(3). 359–387. 2 indexed citations

Patel, Sanjay S., Mikel Lipschitz, Geraldine S. Pinkus, et al.. (2020). Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment. Modern Pathology. 33(7). 1380–1388. 8 indexed citations

10.

Mason, Emily F., et al.. (2020). Durable Long-Term Response in a Patient With Diffuse Large B-Cell Lymphoma Treated With Nivolumab. Clinical Lymphoma Myeloma & Leukemia. 20(11). e934–e936.

11.

Mason, Emily F., Robert P. Hasserjian, Nidhi Aggarwal, Adam C. Seegmiller, & Olga Pozdnyakova. (2019). Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome. Blood Advances. 3(21). 3322–3332. 25 indexed citations

12.

Mason, Emily F., Elizabeth A. Morgan, Geraldine S. Pinkus, & Olga Pozdnyakova. (2017). Cost‐effective approach to the diagnostic workup of B cell lymphoproliferative disorders via optimal integration of flow cytometric data. International Journal of Laboratory Hematology. 39(2). 137–146. 2 indexed citations

13.

Mason, Emily F., Christopher D.�M. Fletcher, & Lynette M. Sholl. (2016). ‘Inflammatory myofibroblastic tumour’‐like dedifferentiation of anaplastic lymphoma kinase‐rearranged lung adenocarcinoma. Histopathology. 69(3). 510–515. 2 indexed citations

14.

Mason, Emily F. & Jason L. Hornick. (2016). Conventional Risk Stratification Fails to Predict Progression of Succinate Dehydrogenase–deficient Gastrointestinal Stromal Tumors. The American Journal of Surgical Pathology. 40(12). 1616–1621. 49 indexed citations

15.

Mason, Emily F. & Jason L. Hornick. (2013). Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis. Modern Pathology. 26(11). 1492–1497. 54 indexed citations

16.

Mason, Emily F., Peter M. Sadow, Andrew J. Wagner, et al.. (2013). Identification of Succinate Dehydrogenase–deficient Bladder Paragangliomas. The American Journal of Surgical Pathology. 37(10). 1612–1618. 15 indexed citations

17.

Michalek, Ryan D., Valerie A. Gerriets, Sarah R. Jacobs, et al.. (2011). Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets. The Journal of Immunology. 186(6). 3299–3303. 1636 indexed citations breakdown →

18.

Mason, Emily F., Yuxing Zhao, Pankuri Goraksha-Hicks, et al.. (2010). Aerobic Glycolysis Suppresses p53 Activity to Provide Selective Protection from Apoptosis upon Loss of Growth Signals or Inhibition of BCR-Abl. Cancer Research. 70(20). 8066–8076. 39 indexed citations

19.

Coloff, Jonathan L., Emily F. Mason, Brian J. Altman, et al.. (2010). Akt Requires Glucose Metabolism to Suppress Puma Expression and Prevent Apoptosis of Leukemic T Cells. Journal of Biological Chemistry. 286(7). 5921–5933. 82 indexed citations

20.

Mason, Emily F. & Jeffrey C. Rathmell. (2010). Cell metabolism: An essential link between cell growth and apoptosis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1813(4). 645–654. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact